A Long-term Follow-up Study in Patients Previously Treated With Mustang Bio, Inc. CAR-T Cell Investigational Products

Study Summary

A long-term follow-up study to assess safety and efficacy in patients previously treated with Mustang Bio chimeric antigen receptor (CAR)-T cell investigational products.

Interventions

Study Locations

Facility	City	State	Country
UC Irvine Health - Chao Family Comprehensive Cancer Center	Orange	California	United States
Massachusetts General Hospital	Boston	Massachusetts	United States
University of Rochester Medical Center	Rochester	New York	United States
Cleveland Clinic	Cleveland	Ohio	United States
Fred Hutchinson Cancer Center	Seattle	Washington	United States

Official Trial Information

View on ClinicalTrials.gov